ACS study: Medicaid expansion increases survival, reduces health disparities for newly diagnosed patients with cancer

Shane Jacobson talks about his to-do list for ACS
Boost research, forge closer ties with cancer centers, launch an all-out campaign for resources

Two months into his job as CEO of the American Cancer Society and American Cancer Society Cancer Action Network, Shane Jacobson is still in the drinking-water-from-the-firehose stage of the job.

November 21, 2025

Vol.51 No.43

Cancer Policy

CMS announces GENEROUS drug payment model aimed at lowering Medicaid drug prices

CMS announced a new drug payment model called the GENErating cost Reductions for U.S. Medicaid (GENEROUS) Model that the agency plans to pilot next year.

November 14, 2025

Vol.51 No.42

By Sara Willa Ernst and Jacquelyn Cobb

Podcast The Directors

The Directors: Steven Artandi and Eric Winer on how looming policy changes “reverberate” through oncology
“Even when funding gets restored and if the H-1B visa threat doesn’t materialize, it creates an environment where especially young people become uncertain.”

With major leadership changes, grant disruptions and terminations, and a stoked distrust in science, Steven Artandi, the director of Stanford Cancer Center, worries that young investigators will feel disenchanted by the U.S. research atmosphere and take their work and study elsewhere.

October 10, 2025

Vol.51 No.37

By Claire Marie Porter and Paul Goldberg

Conversation with The Cancer Letter

Robert Winn: If Medicaid gets massive cuts or goes away, where will these patients get care?

On July 4, President Donald Trump signed into law “The One Big Beautiful Bill Act,” which is expected to deal a massive blow to Medicaid coverage and leave millions without insurance by instituting a work requirement for beneficiaries.

Shane Jacobson named CEO of the American Cancer Society, ACS CAN

Shane Jacobson was appointed CEO of the American Cancer Society and the American Cancer Society Cancer Action Network.

July 25, 2025

Vol.51 No.29

Podcast The Directors

The Directors: Mark Evers and Steven Libutti on riding out the tempest—and maintaining research momentum
As oncology braces for funding, Medicaid cuts, these two directors tell young investigators not to panic

“I don’t think any good cancer center director would be worth their weight in salt if they weren’t worried about something at night,” said Mark Evers, director of University of Kentucky Markey Cancer Center.

July 18, 2025

Vol.51 No.28

By Paul Goldberg and Katie Goldberg

ACS study: Medicaid expansion increases survival, reduces health disparities for newly diagnosed patients with cancer

YOU MAY BE INTERESTED IN

Shane Jacobson talks about his to-do list for ACS
Boost research, forge closer ties with cancer centers, launch an all-out campaign for resources

CMS announces GENEROUS drug payment model aimed at lowering Medicaid drug prices

The Directors: Steven Artandi and Eric Winer on how looming policy changes “reverberate” through oncology
“Even when funding gets restored and if the H-1B visa threat doesn’t materialize, it creates an environment where especially young people become uncertain.”

Robert Winn: If Medicaid gets massive cuts or goes away, where will these patients get care?

Shane Jacobson named CEO of the American Cancer Society, ACS CAN

The Directors: Mark Evers and Steven Libutti on riding out the tempest—and maintaining research momentum
As oncology braces for funding, Medicaid cuts, these two directors tell young investigators not to panic

Renew today!

Subscriber content

Never miss an issue!

Login

ACS study: Medicaid expansion increases survival, reduces health disparities for newly diagnosed patients with cancer

YOU MAY BE INTERESTED IN

Shane Jacobson talks about his to-do list for ACSBoost research, forge closer ties with cancer centers, launch an all-out campaign for resources

CMS announces GENEROUS drug payment model aimed at lowering Medicaid drug prices

The Directors: Steven Artandi and Eric Winer on how looming policy changes “reverberate” through oncology“Even when funding gets restored and if the H-1B visa threat doesn’t materialize, it creates an environment where especially young people become uncertain.”

Robert Winn: If Medicaid gets massive cuts or goes away, where will these patients get care?

Shane Jacobson named CEO of the American Cancer Society, ACS CAN

The Directors: Mark Evers and Steven Libutti on riding out the tempest—and maintaining research momentumAs oncology braces for funding, Medicaid cuts, these two directors tell young investigators not to panic

Never miss an issue!

Login

Shane Jacobson talks about his to-do list for ACS
Boost research, forge closer ties with cancer centers, launch an all-out campaign for resources

The Directors: Steven Artandi and Eric Winer on how looming policy changes “reverberate” through oncology
“Even when funding gets restored and if the H-1B visa threat doesn’t materialize, it creates an environment where especially young people become uncertain.”

The Directors: Mark Evers and Steven Libutti on riding out the tempest—and maintaining research momentum
As oncology braces for funding, Medicaid cuts, these two directors tell young investigators not to panic